TY  - JOUR
AU  - Pedrosa, Lucía
AU  - Fernández-Miranda, Ismael
AU  - Pérez-Callejo, David
AU  - Quero, Cristina
AU  - Rodríguez, Marta
AU  - Martín-Acosta, Paloma
AU  - Gómez, Sagrario
AU  - González-Rincón, Julia
AU  - Santos, Adrián
AU  - Tarin, Carlos
AU  - García, Juan F
AU  - García-Arroyo, Francisco R
AU  - Rueda, Antonio
AU  - Camacho, Francisca I
AU  - García-Cosío, Mónica
AU  - Heredero, Ana
AU  - Llanos, Marta
AU  - Mollejo, Manuela
AU  - Piris-Villaespesa, Miguel
AU  - Gómez-Codina, José
AU  - Yanguas-Casás, Natalia
AU  - Sánchez, Antonio
AU  - Piris, Miguel A
AU  - Provencio, Mariano
AU  - Sánchez-Beato, Margarita
PY  - 2021
DO  - 10.1038/s41598-020-80376-0
UR  - http://hdl.handle.net/10668/17020
T2  - Scientific reports
AB  - Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease whose prognosis is associated with clinical features, cell-of-origin and genetic aberrations. Recent integrative, multi-omic analyses had led to identifying overlapping genetic DLBCL...
LA  - en
KW  - Adult
KW  - Aged
KW  - Algorithms
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - CD79 Antigens
KW  - DNA-Binding Proteins
KW  - Female
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Proteins
KW  - Outcome Assessment, Health Care
KW  - Prognosis
KW  - Receptor, Notch1
KW  - Reproducibility of Results
KW  - Rituximab
TI  - Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.
TY  - research article
VL  - 11
ER  -